These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6979590)

  • 1. Natural mode of acquisition for de novo infection with Pneumocystis carinii.
    Hughes WT
    J Infect Dis; 1982 Jun; 145(6):842-8. PubMed ID: 6979590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of Pneumocystis carinii pneumonia in germ-free rats requires immunosuppression and exposure to the Pneumocystis carinii organism.
    Wolff L; Horch S; Gemsa D
    Comp Immunol Microbiol Infect Dis; 1993 Jan; 16(1):73-6. PubMed ID: 8440087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of Pneumocystis carinii infection in an animal model.
    Evans R; Joss AW; Pennington TH; Ho-Yen DO
    J Med Microbiol; 1998 Jun; 47(6):543-6. PubMed ID: 9879974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals.
    Boylan CJ; Current WL
    Infect Immun; 1992 Apr; 60(4):1589-97. PubMed ID: 1548080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Pneumocystis carinii DNA by filtration of air.
    Olsson M; Sukura A; Lindberg LA; Linder E
    Scand J Infect Dis; 1996; 28(3):279-82. PubMed ID: 8863362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant phospholipids and lavage phospholipase A2 in experimental Pneumocystis carinii pneumonia.
    Sheehan PM; Stokes DC; Yeh YY; Hughes WT
    Am Rev Respir Dis; 1986 Sep; 134(3):526-31. PubMed ID: 3489425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of organism burden and alveolar macrophage counts during infection with Pneumocystis carinii and recovery.
    Lasbury ME; Durant PJ; Bartlett MS; Smith JW; Lee CH
    Clin Diagn Lab Immunol; 2003 Mar; 10(2):293-302. PubMed ID: 12626457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship Between Pneumocystis carinii Burden and the Degree of Host Immunosuppression in an Airborne Transmission Experimental Model.
    Khalife S; Chabé M; Gantois N; Audebert C; Pottier M; Hlais S; Pinçon C; Chassat T; Pierrot C; Khalife J; Aliouat-Denis CM; Aliouat el M
    J Eukaryot Microbiol; 2016 May; 63(3):309-17. PubMed ID: 26509699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of airborne excretion of Pneumocystis carinii during infection in immunocompetent rats. Lung involvement and antibody response.
    Menotti J; Emmanuel A; Bouchekouk C; Chabe M; Choukri F; Pottier M; Sarfati C; Aliouat el M; Derouin F
    PLoS One; 2013; 8(4):e62155. PubMed ID: 23626781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of rat model for Pneumocystis carinii infection and cloning of the surface glycoprotein A gene of Pneumocystis carinii.
    Ouyang LS; Mo QY; Peng HJ; Chen XG; Shen SM
    Di Yi Jun Yi Da Xue Xue Bao; 2002 May; 22(5):427-9. PubMed ID: 12390704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse model for Pneumocystis carinii pneumonia that uses natural transmission to initiate infection.
    Powles MA; McFadden DC; Pittarelli LA; Schmatz DM
    Infect Immun; 1992 Apr; 60(4):1397-400. PubMed ID: 1548065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferation patterns of latent Pneumocystis carinii in rat organs during progressive stages of immunosuppression.
    Reddy LV; Zammit C
    J Protozool; 1991; 38(6):43S-47S. PubMed ID: 1824564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipid composition of Pneumocystis carinii carinii and effects of methylprednisolone immunosuppression on rat lung lipids.
    Guo Z; Kaneshiro ES
    Infect Immun; 1995 Apr; 63(4):1286-90. PubMed ID: 7890386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pneumocystis carinii is still a dangerous opportunist. The infection is continuously a threat to immunocompromised patients].
    Olsson M; Elvin K; Linder E; Löfdahl S; Wahlgren M
    Lakartidningen; 1999 Jan; 96(4):328-31. PubMed ID: 10024821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocystis carinii infection in germ-free rats: implications for human patients.
    Pifer LL; Lattuada CP; Edwards CC; Woods DR; Owens DR
    Diagn Microbiol Infect Dis; 1984 Jan; 2(1):23-36. PubMed ID: 6336148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superiority of methylprednisolone over dexamethasone for induction of Pneumocystis carinii infection in rats.
    Sukura A; Soveri T; Lindberg LA
    J Clin Microbiol; 1991 Oct; 29(10):2331-2. PubMed ID: 1939591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of CD40 ligand and other immunomodulators on Pneumocystis carinii infection in rat model.
    Oz HS; Hughes WT; Rehg JE; Thomas EK
    Microb Pathog; 2000 Sep; 29(3):187-90. PubMed ID: 10968950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A natural source of infection due to pneumocystis carinii.
    Hughes WT; Bartley DL; Smith BM
    J Infect Dis; 1983 Mar; 147(3):595. PubMed ID: 6601170
    [No Abstract]   [Full Text] [Related]  

  • 19. Dynamics of Pneumocystis carinii air shedding during experimental pneumocystosis.
    Choukri F; Aliouat el M; Menotti J; Totet A; Gantois N; Garin YJ; Bergeron V; Dei-Cas E; Derouin F
    J Infect Dis; 2011 May; 203(9):1333-6. PubMed ID: 21372312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on placental transmission of Pneumocystis carinii in mice using immunodeficient SCID mice as a new animal model.
    Ito M; Tsugane T; Kobayashi K; Kuramochi T; Hioki K; Furuta T; Nomura T
    J Protozool; 1991; 38(6):218S-219S. PubMed ID: 1818176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.